Quercetin has been shown to activate AMP-activated protein kinase (AMPK) while inhibiting the mechanistic target of rapamycin (mTOR), mechanisms that collectively enhance autophagy and reduce hepatic lipid accumulation in NAFLD models. Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.